A citation-based method for searching scientific literature

Maria Isabel Achatz, Maira Caleffi, Rodrigo Guindalini, Renato Moretti Marques, Angelica Nogueira-Rodrigues, Patricia Ashton-Prolla. JCO Glob Oncol 2020
Times Cited: 9







List of co-cited articles
29 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Gabriela C Fernandes, Rodrigo A D Michelli, Henrique C R Galvão, André E Paula, Rui Pereira, Carlos E Andrade, Paula S Felicio, Cristiano P Souza, Deise R P Mendes, Sahlua Volc,[...]. Oncotarget 2016
39
44

Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
Juliana Giacomazzi, Marcia S Graudenz, Cynthia A B T Osorio, Patricia Koehler-Santos, Edenir I Palmero, Marcelo Zagonel-Oliveira, Rodrigo A D Michelli, Cristovam Scapulatempo Neto, Gabriela C Fernandes, Maria Isabel W S Achatz,[...]. PLoS One 2014
40
33

Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population.
Gabriela Es Felix, Camila Abe-Sandes, Taísa Mb Machado-Lopes, Thaís F Bomfim, Rodrigo Santa Cruz Guindalini, Vanessa Catarine Sar Santos, Lorena Meyer, Polyanna C Oliveira, João Cláudio Neiva, Roberto Meyer,[...]. Hum Genome Var 2014
29
33

The germline mutational landscape of BRCA1 and BRCA2 in Brazil.
Edenir Inêz Palmero, Dirce Maria Carraro, Barbara Alemar, Miguel Angelo Martins Moreira, Ândrea Ribeiro-Dos-Santos, Kiyoko Abe-Sandes, Henrique Campos Reis Galvão, Rui Manuel Reis, Cristiano de Pádua Souza, Natalia Campacci,[...]. Sci Rep 2018
35
33

Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil.
Nilson Moreira Cipriano, Amanda Marques de Brito, Eneida Santos de Oliveira, Fabiana Castro de Faria, Sara Lemos, Angélica Nogueira Rodrigues, Débora de Oliveira Lopes, Luciana Lara Dos Santos. Breast Cancer 2019
11
33

Population genetic testing for cancer susceptibility: founder mutations to genomes.
William D Foulkes, Bartha Maria Knoppers, Clare Turnbull. Nat Rev Clin Oncol 2016
67
22

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
Beth Crawford, Sophie B Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van 't Veer. Breast Cancer Res Treat 2017
52
22

Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.
Bárbara Alemar, Josef Herzog, Cristina Brinckmann Oliveira Netto, Osvaldo Artigalás, Ida Vanessa D Schwartz, Camila Matzenbacher Bittar, Patricia Ashton-Prolla, Jeffrey N Weitzel. Cancer Genet 2016
23
22

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Allison W Kurian, Kevin C Ward, Ann S Hamilton, Dennis M Deapen, Paul Abrahamse, Irina Bondarenko, Yun Li, Sarah T Hawley, Monica Morrow, Reshma Jagsi,[...]. JAMA Oncol 2018
87
22

Clinical Cancer Genetics Disparities among Latinos.
Marcia Cruz-Correa, Julyann Pérez-Mayoral, Julie Dutil, Miguel Echenique, Rafael Mosquera, Keila Rivera-Román, Sharee Umpierre, Segundo Rodriguez-Quilichini, Maria Gonzalez-Pons, Myrta I Olivera,[...]. J Genet Couns 2017
21
22

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
162
22

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
22

Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark.
Shan Yang, Jennifer E Axilbund, Erin O'Leary, Scott T Michalski, Robbie Evans, Stephen E Lincoln, Edward D Esplin, Robert L Nussbaum. Ann Surg Oncol 2018
35
22

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
22

Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.
Gislaine Custódio, Guilherme A Parise, Nilton Kiesel Filho, Heloisa Komechen, Cesar C Sabbaga, Roberto Rosati, Leila Grisa, Ivy Z S Parise, Mara A D Pianovski, Carmem M C M Fiori,[...]. J Clin Oncol 2013
117
22

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
22

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
Felipe C Silva, Bianca Cg Lisboa, Marcia Cp Figueiredo, Giovana T Torrezan, Erika Mm Santos, Ana C Krepischi, Benedito M Rossi, Maria I Achatz, Dirce M Carraro. BMC Med Genet 2014
45
22

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.
Ingrid Petroni Ewald, Silvia Liliana Cossio, Edenir Inez Palmero, Manuela Pinheiro, Ivana Lucia de Oliveira Nascimento, Taisa Manuela Bonfim Machado, Kiyoko Abe Sandes, Betânia Toralles, Bernardo Garicochea, Patricia Izetti,[...]. Genet Mol Biol 2016
17
22

A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer.
Ana Rafaela de Souza Timoteo, Ana Élida Menezes Magalhães Gonçalves, Lucas Amadeus Porpino Sales, Betina Menezes Albuquerque, Jorge Estefano Santana de Souza, Patrícia Cristina Pascoto de Moura, Marcos Alberto Arruda de Aquino, Lucymara Fassarela Agnez-Lima, Tirzah Braz Petta Lajus. Breast Cancer Res Treat 2018
14
22

Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
Simone da Costa E Silva Carvalho, Nathalia Moreno Cury, Danielle Barbosa Brotto, Luiza Ferreira de Araujo, Reginaldo Cruz Alves Rosa, Lorena Alves Texeira, Jessica Rodrigues Plaça, Adriana Aparecida Marques, Kamila Chagas Peronni, Patricia de Cássia Ruy,[...]. BMC Med Genomics 2020
16
22

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
Holly LaDuca, A J Stuenkel, Jill S Dolinsky, Steven Keiles, Stephany Tandy, Tina Pesaran, Elaine Chen, Chia-Ling Gau, Erika Palmaer, Kamelia Shoaepour,[...]. Genet Med 2014
227
22

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
220
22

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
22

A systematic scoping review of the genetic ancestry of the Brazilian population.
Aracele Maria de Souza, Sarah Stela Resende, Taís Nóbrega de Sousa, Cristiana Ferreira Alves de Brito. Genet Mol Biol 2019
32
22

XAF1 as a modifier of p53 function and cancer susceptibility.
Emilia M Pinto, Bonald C Figueiredo, Wenan Chen, Henrique C R Galvao, Maria Nirvana Formiga, Maria Candida B V Fragoso, Patricia Ashton-Prolla, Enilze M S F Ribeiro, Gabriela Felix, Tatiana E B Costa,[...]. Sci Adv 2020
19
22

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.
Magda C B Gomes, Mauricio M Costa, Radovan Borojevic, Alvaro N A Monteiro, Roberto Vieira, Sergio Koifman, Rosalina Jorge Koifman, Song Li, Robert Royer, Shiyu Zhang,[...]. Breast Cancer Res Treat 2007
56
22

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
284
22

BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
Bárbara Alemar, Cleandra Gregório, Josef Herzog, Camila Matzenbacher Bittar, Cristina Brinckmann Oliveira Netto, Osvaldo Artigalas, Ida Vanessa D Schwartz, Jordy Coffa, Suzi Alves Camey, Jeffrey Weitzel,[...]. PLoS One 2017
21
22

The R337H mutation in TP53 and breast cancer in Brazil.
Magda Cb Gomes, Joanne Kotsopoulos, Gutemberg Leão de Almeida, Mauricio M Costa, Roberto Vieira, Firmino de Ag Filho, Marcos B Pitombo, Paulo Roberto F Leal, Robert Royer, Phil Zhang,[...]. Hered Cancer Clin Pract 2012
26
22

Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.
Jennifer L Caswell-Jin, Anjali D Zimmer, Will Stedden, Kerry E Kingham, Alicia Y Zhou, Allison W Kurian. J Natl Cancer Inst 2019
55
11


The evolutionary history of 2,658 cancers.
Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, Stefan C Dentro, Santiago Gonzalez, Daniel Rosebrock, Thomas J Mitchell, Yulia Rubanova, Pavana Anur, Kaixian Yu,[...]. Nature 2020
304
11

Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990
11

Pathogenic Germline Variants in 10,389 Adult Cancers.
Kuan-Lin Huang, R Jay Mashl, Yige Wu, Deborah I Ritter, Jiayin Wang, Clara Oh, Marta Paczkowska, Sheila Reynolds, Matthew A Wyczalkowski, Ninad Oak,[...]. Cell 2018
339
11

National cancer control plans: a global analysis.
Yannick Romero, Dario Trapani, Sonali Johnson, Zuzanna Tittenbrun, Leslie Given, Karin Hohman, Lisa Stevens, Julie S Torode, Mathieu Boniol, André M Ilbawi. Lancet Oncol 2018
58
11

Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.
Rachel S van der Post, Ingrid P Vogelaar, Fátima Carneiro, Parry Guilford, David Huntsman, Nicoline Hoogerbrugge, Carlos Caldas, Karen E Chelcun Schreiber, Richard H Hardwick, Margreet G E M Ausems,[...]. J Med Genet 2015
314
11

Residential exposure to solar ultraviolet radiation and incidence of childhood hematological malignancies in France.
Astrid Coste, Stéphanie Goujon, Mathieu Boniol, Fabienne Marquant, Laure Faure, Jean-François Doré, Denis Hémon, Jacqueline Clavel. Cancer Causes Control 2015
12
11

Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment.
Deborah J MacDonald, Linda Sarna, Gwen van Servellen, Roshan Bastani, Joyce Newman Giger, Jeffrey N Weitzel. Genet Med 2007
48
11

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
P Hartge, J P Struewing, S Wacholder, L C Brody, M A Tucker. Am J Hum Genet 1999
164
11

Genomics of Cancer and a New Era for Cancer Prevention.
Paul Brennan, Christopher P Wild. PLoS Genet 2015
18
11


A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
209
11

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.
Eric R Manahan, Henry M Kuerer, Molly Sebastian, Kevin S Hughes, Judy C Boughey, David M Euhus, Susan K Boolbol, Walton A Taylor. Ann Surg Oncol 2019
87
11

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
Sining Chen, Edwin S Iversen, Tara Friebel, Dianne Finkelstein, Barbara L Weber, Andrea Eisen, Leif E Peterson, Joellen M Schildkraut, Claudine Isaacs, Beth N Peshkin,[...]. J Clin Oncol 2006
227
11


Disparities in BRCA counseling across providers in a diverse population of young breast cancer survivors.
Sonya Reid, Deborah Cragun, Ann Tezak, Anne Weidner, Jaleesa Moore, Ingrid A Mayer, Xiao-Ou Shu, Fei Ye, Run Fan, Susan Vadaparampil,[...]. Genet Med 2020
5
20

Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis.
Francesca De Felice, Claudia Marchetti, Angela Musella, Innocenza Palaia, Giorgia Perniola, Daniela Musio, Ludovico Muzii, Vincenzo Tombolini, Pierluigi Benedetti Panici. Ann Surg Oncol 2015
40
11

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.
E Warner, W Foulkes, P Goodwin, W Meschino, J Blondal, C Paterson, H Ozcelik, P Goss, D Allingham-Hawkins, N Hamel,[...]. J Natl Cancer Inst 1999
295
11

Genomics of disease risk in globally diverse populations.
Deepti Gurdasani, Inês Barroso, Eleftheria Zeggini, Manjinder S Sandhu. Nat Rev Genet 2019
95
11

Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
Anne Marie McCarthy, Mirar Bristol, Susan M Domchek, Peter W Groeneveld, Younji Kim, U Nkiru Motanya, Judy A Shea, Katrina Armstrong. J Clin Oncol 2016
95
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.